PA-824
Showing 1 - 25 of 1,222
Pulmonary Tuberculosis Trial in Cape Town (PA-824, Rifampin, Rifabutin)
Completed
- Pulmonary Tuberculosis
- PA-824
- +5 more
-
Cape Town, South AfricaUniversity of Cape Town Lung Institute
May 18, 2022
Tuberculosis Trial in United States (PA-824, Efavirenz (EFV), Lopinavir/Ritonavir (LPV/r))
Completed
- Tuberculosis
- PA-824
- +3 more
-
San Francisco, California
- +3 more
Nov 4, 2021
Tuberculosis Trial in Saint Louis, Durham (PA-824)
Recruiting
- Tuberculosis
- PA-824
-
Saint Louis, Missouri
- +1 more
Aug 11, 2022
Pulmonary Tuberculosis Trial in Ysterplaat, Sydenham, Sandringham (Bedaquiline, PA-824, Linezolid)
Completed
- Pulmonary Tuberculosis
- Bedaquiline
- +2 more
-
Ysterplaat, Cape Town, South Africa
- +2 more
Nov 19, 2020
Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Tuberculosis, MDR Trial in Johannesburg, Port Elizabeth, Rustenburg
Recruiting
- Tuberculosis, Pulmonary
- +4 more
- Pretomanid
- +3 more
-
Johannesburg, South Africa
- +2 more
Oct 4, 2021
Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Tuberculosis, MDR Trial in Worldwide (Pretomanid, Linezolid,
Active, not recruiting
- Tuberculosis, Pulmonary
- +5 more
- Pretomanid
- +3 more
-
Tbilisi, Georgia
- +10 more
Jan 26, 2022
Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Tuberculosis, MDR Trial in Worldwide (Pretomanid, Bedaquiline,
Completed
- Tuberculosis, Pulmonary
- +4 more
- Pretomanid
- +5 more
-
Rio de Janeiro, Brazil
- +25 more
Jun 23, 2022
Pulmonary Tuberculosis Trial (PA-824, Rifafour e-275 mg)
Completed
- Pulmonary Tuberculosis
- PA-824
- Rifafour e-275 mg
- (no location specified)
Sep 4, 2019
Multi-drug Resistant Tuberculosis, Extensively Drug-Resistant Tuberculosis, Pulmonary Tuberculosis Trial in Belarus, South
Active, not recruiting
- Multi-drug Resistant Tuberculosis
- +2 more
- Bedaquiline
- +4 more
-
Minsk, Belarus
- +4 more
May 12, 2021
Multi-drug Resistant Tuberculosis, Extensively Drug-Resistant Tuberculosis, Pulmonary Tuberculoses Trial in Belarus, South
Recruiting
- Multi-drug Resistant Tuberculosis
- +2 more
- Bedaquiline
- +5 more
-
Minsk, Belarus
- +6 more
May 12, 2021
Tuberculosis Trial in Lincoln (PA-824 200mg, PA-824 50mg)
Completed
- Tuberculosis
- PA-824 200mg
- PA-824 50mg
-
Lincoln, NebraskaMDS Pharma Services (Celerion)
Sep 4, 2019
Tuberculosis, Multidrug-Resistant, Extensively Drug-Resistant Tuberculosis, Tuberculosis, Pulmonary Trial in Belarus, South
Active, not recruiting
- Tuberculosis, Multidrug-Resistant
- +2 more
- Bedaquiline
- +5 more
-
Minsk, Belarus
- +6 more
May 12, 2021
Multi-drug Resistant Tuberculosis Trial in San Antonio (Pretomanid)
Completed
- Multi-drug Resistant Tuberculosis
-
San Antonio, TexasWorldwide Clinical Trials Early Phase Services, LLC
Mar 13, 2020
Tuberculosis Trial in South Africa, Tanzania, Uganda (PA-824, bedaquiline, moxifloxacin)
Completed
- Tuberculosis
- PA-824
- +4 more
-
Tembisa, Gauteng, South Africa
- +9 more
May 28, 2019
Tuberculosis Trial in Madison (PA-824)
Completed
- Tuberculosis
- PA-824
-
Madison, WisconsinCovance Clinical Research Unit
Aug 1, 2018
Tuberculosis, Pulmonary, Drug Sensitive, Tuberculosis, Pulmonary, Multi Drug-resistant Trial in Worldwide (Moxifloxacin, PA-824,
Completed
- Tuberculosis, Pulmonary, Drug Sensitive
- Tuberculosis, Pulmonary, Multi Drug-resistant
- Moxifloxacin
- +4 more
-
Tbilisi, Georgia
- +25 more
Mar 1, 2019
Nonvalvular Atrial Fibrillation, Health, Subjective Trial in Beijing (Dabigatran etexilate capsule)
Recruiting
- Nonvalvular Atrial Fibrillation
- Health, Subjective
- Dabigatran etexilate capsule
-
Beijing, ChinaPeking University Third Hospital
Feb 6, 2023
Pulmonary Tuberculosis Trial in South Africa, Tanzania (Moxifloxacin (M), Pretomid (Pa), Pyrazinamide (Z))
Completed
- Pulmonary Tuberculosis
- Moxifloxacin (M)
- +3 more
-
Cape Town, South Africa
- +7 more
May 16, 2018
Biliary Atresia Trial in Houston (Pentoxifylline)
Recruiting
- Biliary Atresia
-
Houston, TexasTexas Children's Hospital and Baylor College of Medicine
Feb 1, 2023
Cystic Fibrosis, Sickle Cell Disease, SARS CoV 2 Infection Trial in Irvine (Exercise)
Recruiting
- Cystic Fibrosis
- +2 more
- Exercise
-
Irvine, CaliforniaUniversity of California, Irvine
Jan 5, 2023
Hematopoietic and Lymphoid System Tumor, Malignant Solid Tumor Trial in Scottsdale (Best Practice, Exercise Counseling, Exercise
Not yet recruiting
- Hematopoietic and Lymphoid System Neoplasm
- Malignant Solid Neoplasm
- Best Practice
- +5 more
-
Scottsdale, ArizonaMayo Clinic in Arizona
Oct 12, 2023
Association Between Primary Aldosteronism and Thyroid Cancer
Completed
- Thyroid Cancer, Papillary
- Primary Aldosteronism
- Secreening test for primary aldosteronism and Confirmatory Testing
-
São Paulo, BrazilAna Alice Wolf Maciel
Oct 3, 2023